<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.1d3 20150301//EN"  "JATS-archivearticle1.dtd"><article article-type="research-article" dtd-version="1.1d3" xmlns:xlink="http://www.w3.org/1999/xlink"><front><journal-meta><journal-id journal-id-type="nlm-ta">elife</journal-id><journal-id journal-id-type="hwp">eLife</journal-id><journal-id journal-id-type="publisher-id">eLife</journal-id><journal-title-group><journal-title>eLife</journal-title></journal-title-group><issn publication-format="electronic">2050-084X</issn><publisher><publisher-name>eLife Sciences Publications, Ltd</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">16352</article-id><article-id pub-id-type="doi">10.7554/eLife.16352</article-id><article-categories><subj-group subj-group-type="display-channel"><subject>Tools and Resources</subject></subj-group><subj-group subj-group-type="heading"><subject>Cancer Biology</subject></subj-group></article-categories><title-group><article-title>A hyperspectral method to assay the microphysiological fates of nanomaterials in histological samples</article-title></title-group><contrib-group><contrib contrib-type="author" id="author-54163"><name><surname>SoRelle</surname><given-names>Elliott D</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-3362-1028</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-55480"><name><surname>Liba</surname><given-names>Orly</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-60747"><name><surname>Campbell</surname><given-names>Jos L</given-names></name><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-55481"><name><surname>Dalal</surname><given-names>Roopa</given-names></name><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-60748"><name><surname>Zavaleta</surname><given-names>Cristina L</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" corresp="yes" id="author-55482"><name><surname>de la Zerda</surname><given-names>Adam</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="corresp" rid="cor1">*</xref><xref ref-type="other" rid="par-1"/><xref ref-type="other" rid="par-2"/><xref ref-type="other" rid="par-3"/><xref ref-type="other" rid="par-4"/><xref ref-type="other" rid="par-5"/><xref ref-type="other" rid="par-6"/><xref ref-type="other" rid="par-7"/><xref ref-type="other" rid="par-8"/><xref ref-type="other" rid="par-9"/><xref ref-type="other" rid="par-10"/><xref ref-type="fn" rid="conf1"/></contrib><aff id="aff1"><institution content-type="dept">Molecular Imaging Program at Stanford</institution>, <institution>Stanford University</institution>, <addr-line><named-content content-type="city">Stanford</named-content></addr-line>, <country>United States</country></aff><aff id="aff2"><institution content-type="dept">Ian Potter NanoBioSensing Facility, NanoBiotechnology Research Laboratory, School of Science</institution>, <institution>RMIT University</institution>, <addr-line><named-content content-type="city">Melbourne</named-content></addr-line>, <country>Australia</country></aff><aff id="aff3"><institution content-type="dept">Department of Ophthalmology</institution>, <institution>Stanford University</institution>, <addr-line><named-content content-type="city">Stanford</named-content></addr-line>, <country>United States</country></aff></contrib-group><contrib-group content-type="section"><contrib contrib-type="editor" id="author-14503"><name><surname>Danuser</surname><given-names>Gaudenz</given-names></name><role>Reviewing editor</role><aff><institution>UT Southwestern Medical Center</institution>, <country>United States</country></aff></contrib></contrib-group><author-notes><corresp id="cor1"><label>*</label>For correspondence: <email>adlz@stanford.edu</email> (Ad);</corresp></author-notes><pub-date date-type="pub" publication-format="electronic"><day>18</day><month>08</month><year>2016</year></pub-date><volume>5</volume><elocation-id>e16352</elocation-id><history><date date-type="received"><day>24</day><month>03</month><year>2016</year></date><date date-type="accepted"><day>16</day><month>08</month><year>2016</year></date></history><permissions><copyright-statement>Â© 2016, SoRelle et al</copyright-statement><copyright-year>2016</copyright-year><copyright-holder>SoRelle et al</copyright-holder><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><license-p>This article is distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link> permitting unrestricted use and redistribution provided that the original author and source are credited.</license-p></license></permissions><self-uri content-type="pdf" xlink:href="elife-16352-v1.pdf"/><abstract><p>Nanoparticles are used extensively as biomedical imaging probes and potential therapeutic agents. As new particles are developed and tested <italic>in vivo</italic>, it is critical to characterize their biodistribution profiles. We demonstrate a new method that uses adaptive algorithms for analysis of hyperspectral dark-field images to study the interactions between tissues and administered nanoparticles. This non-destructive technique quantitatively identifies particles in <italic>ex vivo</italic> tissue sections and enables detailed observations of accumulation patterns arising from organ-specific clearance mechanisms, particle size, and the molecular specificity of nanoparticle surface coatings. Unlike nanoparticle uptake studies with electron microscopy, this method is tractable for imaging large fields of view. Adaptive hyperspectral image analysis achieves excellent detection sensitivity and specificity and is capable of identifying single nanoparticles. Using this method, we collected the first data on the sub-organ distribution of several types of gold nanoparticles in mice and observed localization patterns in tumors.</p></abstract><kwd-group kwd-group-type="research-organism"><title>Research organism</title><kwd>Mouse</kwd></kwd-group><funding-group><award-group id="par-1"><funding-source><institution-wrap><institution>Claire Giannini Fund</institution></institution-wrap></funding-source><principal-award-recipient><name><surname>de la Zerda</surname><given-names>Adam</given-names></name></principal-award-recipient></award-group><award-group id="par-2"><funding-source><institution-wrap><institution>Stanford Bio-X Interdisciplinary Initiative Seed Grant</institution></institution-wrap></funding-source><principal-award-recipient><name><surname>de la Zerda</surname><given-names>Adam</given-names></name></principal-award-recipient></award-group><award-group id="par-3"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100006831</institution-id><institution>U.S. Air Force</institution></institution-wrap></funding-source><award-id>FA9550-15-1-0007</award-id><principal-award-recipient><name><surname>de la Zerda</surname><given-names>Adam</given-names></name></principal-award-recipient></award-group><award-group id="par-4"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000002</institution-id><institution>National Institutes of Health</institution></institution-wrap></funding-source><award-id>NIH DP50D012179</award-id><principal-award-recipient><name><surname>de la Zerda</surname><given-names>Adam</given-names></name></principal-award-recipient></award-group><award-group id="par-5"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100001021</institution-id><institution>Damon Runyon Cancer Research Foundation</institution></institution-wrap></funding-source><award-id>DFS# 06-13</award-id><principal-award-recipient><name><surname>de la Zerda</surname><given-names>Adam</given-names></name></principal-award-recipient></award-group><award-group id="par-6"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100009634</institution-id><institution>Susan G. Komen</institution></institution-wrap></funding-source><award-id>SAC15-00003</award-id><principal-award-recipient><name><surname>de la Zerda</surname><given-names>Adam</given-names></name></principal-award-recipient></award-group><award-group id="par-7"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000983</institution-id><institution>Mary Kay Foundation</institution></institution-wrap></funding-source><award-id>017-14</award-id><principal-award-recipient><name><surname>de la Zerda</surname><given-names>Adam</given-names></name></principal-award-recipient></award-group><award-group id="par-8"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100007491</institution-id><institution>Donald E. and Delia B. Baxter Foundation</institution></institution-wrap></funding-source><principal-award-recipient><name><surname>de la Zerda</surname><given-names>Adam</given-names></name></principal-award-recipient></award-group><award-group id="par-9"><funding-source><institution-wrap><institution>Skippy Frank Foundation</institution></institution-wrap></funding-source><principal-award-recipient><name><surname>de la Zerda</surname><given-names>Adam</given-names></name></principal-award-recipient></award-group><award-group id="par-10"><funding-source><institution-wrap><institution>Center for Cancer Nanotechnology Excellence and Translation</institution></institution-wrap></funding-source><award-id>CCNE-T U54CA151459</award-id><principal-award-recipient><name><surname>de la Zerda</surname><given-names>Adam</given-names></name></principal-award-recipient></award-group><funding-statement>The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.</funding-statement></funding-group></article-meta></front><back><sec id="s1" sec-type="additional-information"><title>Additional information</title><fn-group content-type="competing-interest"><title>Competing interest</title><fn fn-type="conflict" id="conf1"><p>The authors declare that no competing interests exist.</p></fn></fn-group><fn-group content-type="ethics-information"><title>Ethics</title><fn fn-type="other"><p>Animal experimentation: All animal experiments in this study were performed in compliance with IACUC guidelines and with the Stanford University Animal Studies Committee's Guidelines for the Care and Use of Research Animals (APLAC Protocol #27499 and #29179).</p></fn></fn-group></sec><sec sec-type="supplementary-material"><supplementary-material><ext-link xlink:href="elife-16352-supp-v1.zip">Download zip</ext-link><p>Any figures and tables for this article are included in the PDF. The zip folder contains additional supplemental files.</p></supplementary-material></sec></back></article>